Efficacy and safety of treatment with ampasse: the results of a randomized, double-blind, placebo-controlled trial in patients with chronic cerebrovascular disorders-Reference-Cited by-同舟云学术

Efficacy and safety of treatment with ampasse: the results of a randomized, double-blind, placebo-controlled trial in patients with chronic cerebrovascular disorders

Published:2021 Issue:5 Volume:121 Page:26
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Skoromets A.A.,Kotov S.V.,Voronkov P.B.,Popova V.V.,Zubkova T.G.,Kiselev A.V.

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Clinical Neurology

Reference39 articles.

1. Global Stroke Statistics 2019

2. Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe

3. Vascular Cognitive Impairment

4. The impact of cerebrovascular aging on vascular cognitive impairment and dementia

5. Cerebral Small Vessel Disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the Start Time of Cognitive Rehabilitation after Ischemic Stroke on the Level of Recovery;Neuroscience and Behavioral Physiology;2024-01

2. Observational study of the efficacy and safety of the drug Ampasse in patients with moderate cognitive impairment in chronic cerebral ischemia;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

3. The effect of the start date of cognitive rehabilitation after ischemic stroke on the level of recovery;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

4. Ampakines — a promising approach to neuroprotection;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2022

5. Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2021